Renuka Iyer Selected Research

Octreotide (Sandostatin)

3/2022	Health-Related Quality of Life (HRQoL) in Neuroendocrine Tumors: A Systematic Review.
1/2016	Octreotide and Lanreotide in Gastroenteropancreatic Neuroendocrine Tumors.
7/2011	Sandostatin desensitization--a strategy useful for patients with carcinoid tumors, intolerant to sandostatin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Renuka Iyer Research Topics

Disease

34	Neoplasms (Cancer) 01/2022 - 01/2005
16	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 01/2005
10	Pancreatic Neoplasms (Pancreatic Cancer) 12/2019 - 09/2009
5	Carcinoid Tumor (Carcinoid) 03/2022 - 07/2011
5	Adenocarcinoma 12/2021 - 08/2008
5	Disease Progression 01/2021 - 06/2014
4	Esophageal Neoplasms (Esophageal Cancer) 08/2014 - 07/2005
3	Neuroendocrine Tumors (Neuroendocrine Tumor) 03/2022 - 01/2016
3	Liver Neoplasms (Liver Cancer) 01/2021 - 08/2010
3	Carcinogenesis 07/2015 - 08/2010
2	Diarrhea 03/2022 - 04/2017
2	Breast Neoplasms (Breast Cancer) 12/2021 - 08/2014
2	Neoplasm Metastasis (Metastasis) 01/2021 - 06/2016
2	Infections 03/2020 - 01/2018
2	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2019 - 07/2015
2	Chronic Hepatitis B 01/2019 - 01/2018
2	Exanthema (Rash) 09/2017 - 02/2010
2	Carcinoma (Carcinomatosis) 03/2013 - 01/2013
2	Renal Cell Carcinoma (Grawitz Tumor) 08/2010 - 09/2009
1	Cytopenia 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 12/2021
1	Esophageal and Gastric Varices (Esophageal Varices) 12/2020
1	Liver Diseases (Liver Disease) 12/2020
1	Hepatitis 03/2020
1	Thrombosis (Thrombus) 06/2019
1	Pain (Aches) 06/2019
1	Prostatic Neoplasms (Prostate Cancer) 05/2019
1	Virus Diseases (Viral Diseases) 01/2019
1	Hypercalcemia (Milk Alkali Syndrome) 10/2018
1	Cholangiocarcinoma 01/2018

Drug/Important Bio-Agent (IBA)

11	Gemcitabine FDA Link 12/2021 - 09/2009
9	Biomarkers (Surrogate Marker)IBA 01/2020 - 02/2010
7	Sorafenib (BAY 43-9006)FDA Link 12/2020 - 08/2010
4	Sunitinib (Sutent)FDA Link 03/2022 - 09/2009
4	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2017 - 02/2010
3	Octreotide (Sandostatin)FDA LinkGeneric 03/2022 - 07/2011
3	Bevacizumab (Avastin)FDA Link 12/2020 - 06/2014
3	ErbB Receptors (EGF Receptor)IBA 03/2013 - 08/2008
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 03/2022 - 01/2016
2	lanreotide (Somatuline)FDA Link 03/2022 - 01/2016
2	Tyrosine Kinase InhibitorsIBA 12/2020 - 02/2010
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2020 - 08/2008
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2020 - 08/2014
2	Fluorouracil (Carac)FDA LinkGeneric 01/2020 - 08/2014
2	tivozanibIBA 01/2020 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 05/2019 - 08/2014
2	Capecitabine (Xeloda)FDA Link 01/2019 - 08/2017
2	Angiogenesis InhibitorsIBA 07/2016 - 08/2010
2	Phosphotransferases (Kinase)IBA 01/2016 - 08/2010
2	PlatinumIBA 08/2014 - 01/2013
2	DNA (Deoxyribonucleic Acid)IBA 07/2013 - 03/2013
2	ParaffinIBA 03/2013 - 12/2005
2	Pharmaceutical PreparationsIBA 07/2011 - 02/2010
1	Peptide Receptors (Peptide Receptor)IBA 03/2022
1	Everolimus FDA Link 03/2022
1	JNK Mitogen-Activated Protein KinasesIBA 12/2021
1	Anaplastic Lymphoma KinaseIBA 12/2021
1	Cetuximab (Erbitux)FDA Link 12/2021
1	ceritinibIBA 12/2021
1	pembrolizumabIBA 12/2021
1	Proto-Oncogene Proteins c-metIBA 12/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	atezolizumabIBA 12/2020
1	lenvatinibIBA 12/2020
1	Androgen Receptors (Androgen Receptor)IBA 12/2020
1	enzalutamideIBA 12/2020
1	SurvivinIBA 06/2020
1	Protons (Proton)IBA 03/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Leucovorin (Folinic Acid)FDA Link 01/2020
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2020
1	10-propargyl-10-deazaaminopterin FDA Link 01/2020
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2019
1	Clofarabine (Clolar)FDA Link 11/2019
1	Interleukin-6 (Interleukin 6)IBA 06/2019
1	AcidsIBA 05/2019
1	Carboxylic AcidsIBA 05/2019
1	Methionine (L-Methionine)FDA Link 05/2019
1	Amino Acids FDA Link 05/2019
1	4- amino- 5- fluoro- 3- (5- (4- methylpiperazin- 1- yl)- 1H- benzimidazol- 2- yl)quinolin- 2(1H)- oneIBA 01/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019
1	Calcitriol Receptors (Calcitriol Receptor)IBA 10/2018
1	paricalcitol (Zemplar)FDA Link 10/2018
1	Calcitriol (Calcijex)FDA LinkGeneric 10/2018
1	LigandsIBA 10/2018
1	Monoclonal AntibodiesIBA 01/2018
1	Amylases FDA Link 01/2018
1	entecavir FDA Link 01/2018
1	Lipase (Acid Lipase)FDA Link 01/2018

Therapy/Procedure

24	Therapeutics 03/2022 - 07/2005
10	Drug Therapy (Chemotherapy) 03/2022 - 12/2005
2	Combination Drug Therapy (Combination Chemotherapy) 01/2021 - 09/2009
2	Immunotherapy 01/2021 - 01/2019
2	Pancreatectomy 03/2013 - 03/2007
2	Radiotherapy 01/2013 - 08/2008
1	Radiofrequency Ablation 03/2022
1	Contraindications 12/2020
1	Adjuvant Chemotherapy 12/2019
1	Immunomodulation 02/2018